Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Framework for Aripiprazole prolonged release injection

NHS England

This public procurement record has 5 releases in its history.

Award

25 Aug 2026 at 17:56

UK7 - Contract Details Notice
Award

29 Jul 2026 at 12:22

UK6 - Contract Award Notice
Tender

27 May 2026 at 13:46

UK4 - Tender Notice
Planning

02 Apr 2026 at 11:05

UK2 - Preliminary Market Engagement Notice
Planning

12 Mar 2026 at 15:56

UK1 - Pipeline Notice
Summary of the contracting process

NHS England procured a national framework for aripiprazole prolonged-release injection, a pharmaceutical product used in NHS services. The requirement covers the supply of this medicine to purchasing points across England, including the North East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London and the South West. It is a goods procurement managed by NHS England’s medicines procurement and supply chain function. The framework is intended for NHS purchasing organisations and pharmacy supply points. The product scope is specific rather than a broad medicines catalogue: businesses should have a commercial interest in aripiprazole prolonged-release injection and the ability to supply it through NHS procurement arrangements.

The procurement is complete and has been awarded under an open procedure, with a framework agreement using reopening of competition. One lot was awarded to Otsuka Pharmaceuticals UK Limited, Perennial Pharma Ltd and Sun Pharma UK Ltd; Orifarm UK also submitted a valid tender. The award date was 29 July 2026 and the contract was signed on 14 August 2026. The contract runs from 1 February 2027 to 31 January 2029, with Authority-held extension options of up to 24 months, to a maximum end date of 31 January 2031. The awarded value is £32,140,000 excluding VAT, or £38,568,000 including VAT. Four valid bids were received. Price was the stated award criterion, weighted at 100%.

This award is a clear signal of NHS demand for aripiprazole prolonged-release injection at national framework scale. Relevant competitors are pharmaceutical companies able to bring the specified molecule and formulation to market, maintain reliable supply to NHS purchasing points across England, and participate in a framework with further competition when individual requirements are called off. The tender process included a procurement-specific questionnaire, product listing and usage information, a quality assurance process, a quality-control technical sheet, and framework terms and conditions. A credible future supplier would therefore need strong regulatory, manufacturing, quality-control, supply-chain and NHS commercial capability, together with the capacity to provide the required product consistently and respond to purchasing-point requirements.

How relevant is this notice?

Notice Information

Notice Title

NHS National Framework for Aripiprazole prolonged release injection

Notice Description

Project title: NHS National Framework for Aripiprazole prolonged release injection commencing 1st February 2027 Offer reference number: CM/TNS/26/5741 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5741 Aripiprazole prolonged release injection Lot 1 CESW 01/02/2027 to 30/09/2027 (8 months) Lot 2 NWLN 01/02/2027 to 31/01/2029 (24 months) Lot 3 LSNE 01/02/2027 to 31/05/2028 (16 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Lot Information

Lot 1

Renewal: Option or options to extend (at the discretion of the Authority) up to a maximum of 24 months

Planning Information

NHS England is seeking to engage with current or potential new suppliers that are planning to launch any of the molecules that will be covered by this procurement. Interested suppliers will be invited to a virtual preliminary market engagement meeting. The purpose of these sessions is to update suppliers regarding timelines and to discuss product details, product launches during the proposed framework period, tender structure, and KPI's. Please contact katie.noonan@nhs.net or marie.graney1@nhs.net to register your interest in tendering for this framework.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-0668bf
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/081037-2026
Current Stage
Award
All Stages
Planning, Tender, Award

Procurement Classification

Notice Type
UK7 - Contract Details Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£24,467,000 £10M-£100M
Lots Value
£24,467,000 £10M-£100M
Awards Value
£32,140,000 £10M-£100M
Contracts Value
£32,140,000 £10M-£100M

Notice Dates

Publication Date
25 Aug 2026Yesterday
Submission Deadline
26 Jun 2026Expired
Future Notice Date
27 May 2026Expired
Award Date
29 Jul 20264 weeks ago
Contract Period
1 Feb 2027 - 31 Jan 2029 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
NHS England
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
SE1 8UG
Postcode Area
South East London
Country
England
Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI45 Lambeth
Delivery Location
TLC North East (England), TLD North West (England), TLF East Midlands (England), TLG West Midlands (England), TLH East (England), TLJ South East (England), TLK South West (England)
Local Authority
Lambeth
Electoral Ward
Waterloo & South Bank
Westminster Constituency
Vauxhall and Camberwell Green

Supplier Information

Number of Suppliers
3
Supplier Names

Otsuka Pharmaceuticals UK Limited

Perennial Pharma Ltd

Sun Pharma UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...